Alba Fiorentino: Honored to participate in the Oligocare study organized by the ESTRO and EORTC
Alba Fiorentino, Associate Professor of Radiation Oncology at LUM University of Medicine, shared on LinkedIn:
“We are honored to participate in the Oligocare study organized by the European Society for Radiotherapy and Oncology (ESTRO) and EORTC – European Organisation for Research and Treatment of Cancer.
Regional General Hospital F. Miulli stands out as the only center in southern Italy participating in this protocol.
The research indicated that radiotherapy, along with medical therapy, effectively treats even advanced forms of cancer, comparable to surgery but with less impact on patients.
Oligocare is a cohort of the E2RADIatE platform.
We are actively recruiting patients diagnosed with oligometastatic breast, lung, colon, rectal, and prostate cancer.
Join ESTRO and EORTC in the fight against cancer, contributing to advancements that could benefit many.”
EORTC shared this post on LinkedIn, adding:
“We are proud to have Regional General Hospital F. Miulli and Alba Fiorentino on board E²-RADIatE platform’ OligoCare cohort.
The E2RADIatE platform is supported by Walgreens Boots Alliance.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023